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Abstract
Periodontal (gum) disease is one of the main global oral health burdens and severe periodontal disease (periodontitis) is a
leading cause of tooth loss in adults globally. It also increases the risk of cardiovascular disease and diabetes mellitus.
Porphyromonas gingivalis lipopolysaccharide (LPS) is a key virulent attribute that significantly contributes to periodontal
pathogenesis. Baicalin is a flavonoid from Scutellaria radix, an herb commonly used in traditional Chinese medicine for
treating inflammatory diseases. The present study examined the modulatory effect of baicalin on P. gingivalis LPS-induced
expression of IL-6 and IL-8 in human oral keratinocytes (HOKs). Cells were pre-treated with baicalin (0–80 mM) for 24 h, and
subsequently treated with P. gingivalis LPS at 10 mg/ml with or without baicalin for 3 h. IL-6 and IL-8 transcripts and proteins
were detected by real-time polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. The
expression of nuclear factor-kB (NF-kB), p38 mitogen-activated protein kinase (MAPK) and c-Jun N-terminal kinase (JNK)
proteins was analyzed by western blot. A panel of genes related to toll-like receptor (TLR) signaling was examined by PCR
array. We found that baicalin significantly downregulated P. gingivalis LPS-stimulated expression of IL-6 and IL-8, and
inhibited P. gingivalis LPS-activated NF-kB, p38 MAPK and JNK. Furthermore, baicalin markedly downregulated P. gingivalis
LPS-induced expression of genes associated with TLR signaling. In conclusion, the present study shows that baicalin may
significantly downregulate P. gingivalis LPS-upregulated expression of IL-6 and IL-8 in HOKs via negative regulation of TLR
signaling.
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Introduction
Periodontal disease is one of the main global oral health burdens
and severe periodontal disease (periodontitis) is a major cause of
tooth loss in adults globally [1]. Emerging evidence shows that it
also increases the risk of some life-threating diseases like
cardiovascular disease and diabetes mellitus [2–4]. Periodontitis
is characterized by bacteria-induced, uncontrolled inflammatory
destruction of tooth-supporting tissues and alveolar bone in
susceptible individuals [5]. Porphyromonas gingivalis is a major
periodontal pathogen and its lipopolysaccharide (LPS) is one of
the key virulent attributes that significantly contributes to
periodontal pathogenesis [6,7]. It can stimulate the host to
produce a variety of pro-inflammatory cytokines like IL-6 and
IL-8, thereby involving in the initiation and progression of
periodontal disease [8–10].
Toll-like receptors (TLRs) are a family of pattern recognition
receptors (PRRs) that recognize microbial components and
mediate the activation of host response [11]. Microbial LPS
utilizes TLR4 to activate nuclear factor-kB (NF-kB), p38 mitogen-
activated protein kinase (MAPK) and c-Jun N-terminal kinase
(JNK), leading to the production of pro-inflammatory cytokines
[11]. This process requires an initial recruitment of myeloid
differentiation primary-response protein 88 (MyD88) to TLR4
[12–14]. In addition, there exists a TLR4-mediated MyD88-
independent pathway that recruits toll/interleukin-1 receptor
(TIR) domain-containing adaptor inducing interferon-b (TRIF)
instead of recruitment of MyD88 to TLR4 in response to LPS,
thereby activating the expression of interferon (IFN)-b and IFN-
inducible genes like chemokine (C-X-C motif) ligand 10
(CXCL10) [15–18]. LPS is a TLR4 ligand and P. gingivalis LPS
interacts with TLR4 to activate host response [19–21]. Neverthe-
less, it has been reported that P. gingivalis LPS could interact with
TLR2 as well [22–24], due to the heterogeneity in lipid A
structure of P. gingivalis LPS [8,25,26], and/or the contamination
of LPS with some bioactive molecules like phosphorylated lipids
and lipoproteins [27–29].
Recently, host modulatory therapy (HMT) has been proposed
as a promising adjunct to conventional periodontal treatment
[30,31]. Some examples of HMT in treatment of periodontitis
include subantimicrobial dose of doxycycline, lipoxins and resolvin
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E1 [32–34]. Scutellariae radix is an herb that has been used to treat
inflammatory diseases in traditional Chinese medicine (TCM)
since ancient times [35]. Baicalin is a flavonoid isolated from
Scutellaria radix and it can suppress IL-8-induced metalloproteinase-
8 (MMP-8) expression in human neutrophils [36]. In periodontal
research, it has recently been shown that baicalin enables to inhibit
the transcription of receptor activator of NF-kB ligand (RANKL)
in human periodontal ligament cells, and reduces the loss of bone
and collagens in rat models of periodontitis [37,38]. Furthermore,
baicalin may inhibit IL-1b-induced MMP-1 expression and
stimulate collagen-I production in human periodontal ligament
cells [39].
In the present study, we found that baicalin significantly
downregulated P. gingivalis LPS-upregulated expression of IL-6 and
IL-8. Baicalin also inhibited P. gingivalis LPS-induced activation of
NF-kB, p38 MAPK and JNK proteins, and markedly downreg-
ulated P. gingivalis LPS-induced expression of genes associated with
TLR signaling, such as chemokine (C-C motif) ligand 2 (CCL2),
granulocyte colony-stimulating factor (G-CSF or CSF3) and
CXCL10.
Materials and Methods
Cell Culture
HOKs isolated from normal human oral mucosa (Sciencell, CA,
USA) were cultured according to the manufacturer’s instructions.
Prior to cell culture, culture vessels were coated with poly-L-lysine
(Sigma, MO, USA) at 2 mg/cm2 at 37uC for 1 h. Cells were
seeded at 5000 cells/cm2 with the oral keratinocyte medium
(Sciencell). The incubation condition was set at 37uC with an
atmosphere of 5% CO2 and 95% air. The medium was changed
every two days for the first four days and daily thereafter until a
monolayer was formed.
Preparation of P. gingivalis LPS and Baicalin
Lyophilized LPS from P. gingivalis with type II fimA (strain code
TDC60) was kindly provided by Prof. Y. Abiko (Nihon University,
Japan). The LPS was prepared using the hot phenol water method
[40,41]. It was reconstituted in Dulbecco’s phosphate-buffered
saline (DPBS) to a concentration of 1.0 mg/ml, followed by
filtration through a 0.2 mm cellulose acetate membrane filter
(Millipore, MA, USA). Baicalin powder (solvent extracted with a
purity .95% as tested by HPLC) was obtained from the Hong
Kong Jockey Club Institute of Chinese Medicine, Hong Kong. It
was dissolved in pure dimethyl sulfoxide (DMSO) (Sigma), and
then diluted in DPBS to 1.0 mM and finally filtered for
sterilization. Working solutions were made with fresh oral
keratinocyte medium on the experiment day.
Total RNA Extraction and cDNA Synthesis
Total RNA was extracted using the RNeasy mini kit (Qiagen,
CA, USA). Briefly, cells were lysed with the buffer RLT, and the
lysate was applied to an RNeasy Mini spin column. After several
rounds of washes using the buffer RW1 and RPE, total RNA was
bound to the column and other cell components were efficiently
washed away. At the end, total RNA was eluted in RNase-free
water. To avoid the contamination of genomic DNA, on-column
DNase digestion was performed during RNA purification. The
concentration of purified RNA was quantified by measuring its
260 nm UV absorbance on a NanoDrop spectrophotometer
(Thermo, MA, USA). The integrity of purified RNA was evaluated
by checking the ratio of 28 S rRNA and 18 S rRNA bands on an
agarose gel. cDNA was synthesized using the Quantitect Reverse
Transcription Kit (Qiagen). In brief, 1.0 mg of total RNA was pre-
incubated with the gDNA Wipeout Buffer at 42uC for 2 min to
remove any residual genomic DNA. The mixture was then
incubated with the Quantiscript Reverse Transcriptase, Quanti-
script RT Buffer and RT Primer Mix at 42uC for 30 min, followed
by a termination step at 95uC for 5 min.
Real-time Polymerase Chain Reaction (PCR)
Each real-time PCR reaction mix contained 10.0 ml of the
QuantiFast SYBR green master mix (Qiagen), 1.0 ml of cDNA
template (5.0 ng), 1.0 ml of forward primer (10 mM), 1.0 ml of
reverse primer (10 mM) and 7.0 ml of ultra-pure water. The
reaction condition was set as follows: an initial activation at 95uC
for 5 min, followed by 40 cycles at 95uC for 10 s and 60uC for
30 s. The primer sequences were: for IL-6, 59-AATCAT-
CACTGGTCTTTTGGAG (forward), 59-
GCATTTGTGGTTGGGTCA (reverse); and for IL-8, 59-GA-
CATACTCCAAACCTTTCCACC (forward), 59- AACTTCTC-
CACAACCCTCTGC (reverse); for b-actin (ACTB),59-
TTGGCAATGAGCGGTT (forward), 59-AGTTGAAGG-
TAGTTTCGTGGAT (reverse). All the primers were designed
to amplify a region that lasts 100–250 base pairs long and contains
at least one intron. They had passed our in-house amplification
efficiency and specificity tests prior to usage. To check for
nonspecific primer binding or co-amplification of residual genomic
DNA, the melting curve was analyzed after each running. To
detect foreign DNA contamination, a no-template control which
contained all the reagents except the cDNA template was included
in each running. Raw fluorescence data were analyzed by an Excel
workbook called DART-PCR which automatically calculates
threshold cycles, relative quantification values and amplification
efficiencies [42].
Enzyme-linked Immunosorbent Assay (ELISA)
ELISA kits (R&D, MN, USA) were used to quantitatively
determine the concentrations of IL-6 and IL-8 in culture
supernatants. In brief, protein samples were pipetted into a
microplate pre-coated with anti-IL-6 or anti-IL-8 antibodies and
incubated at room temperature (RT) for 2 h. The plate was then
washed three times with washing buffer to remove unbound
samples. Subsequently, enzyme-linked polyclonal anti-IL-6 or
anti-IL-8 antibodies were added and incubated at RT for 1 h.
Following another three washes, a substrate solution was added
and incubated at RT for 20 min. A blue color was then developed
in direct proportion to the amount of the target cytokine in each
well. Lastly, a stop solution was added to stop the color reaction.
The absorbance was measured at 450 nm by a microplate reader
(PerkinElmer, MA, USA).
Protein Extraction
Cytoplasmic and nuclear proteins were extracted using the NE-
PER Nuclear and Cytoplasmic Extraction kit (Thermo). Two
reagents, the Cytoplasmic Extraction Reagents I and II, were
added to cell pellets to lyse cells. The cytoplasmic proteins released
were collected by centrifugation. The remaining intact nuclei were
lysed with the Nuclear Extraction Reagent and the nuclear
proteins released were collected by centrifugation. The concen-
trations of fractionated proteins were measured by the BCA
protein assay kit (Thermo).
Western Blot
Protein samples were separated on 10% SDS-polyacrylamide
gels by electrophoresis and subsequently transferred to polyviny-
lidene difluoride membranes (Roche, IN, USA) by using the Mini-
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PROTEAN tetra electrophoresis system and Mini Trans-Blot
transfer system (Bio-rad, CA, USA). Afterwards, the membranes
were incubated with the Protein-Free T20 (TBS) Blocking Buffer
(Thermo) at RT for 1 h and then probed with the primary
antibodies (1:2000) at 4uC overnight with gentle agitation. On the
next day, the membranes were washed and incubated with
horseradish peroxidase (HRP)-conjugated secondary antibodies at
RT for 1 h. They were then washed again and incubated with the
SuperSignal West Pico Chemiluminescent Substrate (Thermo) for
5 min. The signals of antigen-antibody complexes were developed
on X-ray films. The density of the developed bands was quantified
by the ImageJ software. The rabbit monoclonal antibodies (mAbs)
against human IkBa, phospho-IkBa (serine32), phospho-p38
MAPK (Thr180/Tyr182), phospho-JNK (Thr183/Tyr185) and
a-tubulin were obtained from Cellsignaling (MA, USA). HRP-
conjugated goat polyclonal antibodies against rabbit IgG were
obtained from Thermo.
NF-kB p65 Transcription Factor Assay
A NF-kB p65 Transcription Factor Kit (Thermo) was used to
measure the level of p65 transcription factor in nuclear protein
samples. It contains a 96-well plate pre-coated with a biotinylated
consensus DNA sequence which only binds p65. Briefly, nuclear
protein samples were added to each well with binding buffer and
incubated at RT for 1 h. The plate was then washed and
incubated with primary anti-p65 antibody at RT for 1 h.
Figure 1. Baicalin significantly downregulates P. gingivalis LPS-upregulated IL-6 expression. A. Baicalin (BI) at 40 mM and 80 mM
significantly downregulated P. gingivalis (P.g.) LPS-upregulated IL-6 mRNA expression. B. Baicalin at 10 mM, 20 mM, 40 mM, and 80 mM markedly
downregulated P.g. LPS-upregulated IL-6 protein expression. Cells treated with culture media alone served as the blank control group, and those
treated with P.g. LPS (10 mg/ml) alone represented the positive control group. Cells treated with 0.08% DMSO and P.g. LPS at 10 mg/ml served as the
vehicle control group. Data of three independent experiments were depicted as relative fold change as compared with the blank control group (set
as 1) (A), or presented as protein concentration (B). *p,0.05 and **p,0.01 as compared with the positive control group (P.g. LPS).
doi:10.1371/journal.pone.0051008.g001
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Following another around of washing, secondary HRP-conjugated
antibodies were added to the plate and incubated at RT for 1 h.
Lastly, a chemiluminescent substrate solution was added to the
wells. The signal image was captured with a CCD camera and the
signal intensity was measured by a multiplate reader.
PCR Array
A panel of 89 genes associated with TLR signal transduction
was investigated simultaneously using the RT2 ProfilerTM PCR
Arrays (SAbiosciences, MD, USA). RNA samples were firstly
reverse transcribed into cDNA templates by the RT2 First Strand
Kit (SAbiosciences). The diluted cDNA templates were subse-
quently mixed with the RT2 qPCR Master Mix (SAbiosciences)
and H2O. 25 ml of the mixture were loaded into each well of the
array plate which contained pre-coated specific primers. The real-
time PCR was performed as follows: an initial incubation at 95uC
for 10 min, then 40 cycles at 95uC for 15 s and 60uC for 1 min.
Data analysis was undertaken by using the SAbiosciences web-
based PCR array data analysis software.
Statistical Analysis
All experiments were repeated three times. The data were
presented as mean6SD and the statistical significance was
evaluated by one way ANOVA using the SPSS 16.0 software. A
p-value,0.05 was considered statistically significant.
Figure 2. Baicalin significantly downregulates P. gingivalis LPS-upregulated IL-8 expression. A. Baicalin (BI) at 80 mM significantly
downregulated P. gingivalis (P.g.) LPS-upregulated IL-8 mRNA expression. B. Baicalin at 80 mM significantly downregulated P.g. LPS-upregulated IL-8
protein expression. Cells treated with culture media alone served as the blank control group, and those treated with P.g. LPS (10 mg/ml) alone
represented the positive control group. Cells treated with 0.08% DMSO and P.g. LPS at 10 mg/ml served as the vehicle control group. Data of three
independent experiments were depicted as relative fold change as compared to the blank control group (set as 1) (A), or presented as protein
concentration (B). *p,0.01 as compared with the positive control group (P.g. LPS).
doi:10.1371/journal.pone.0051008.g002
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Results
Baicalin Downregulated P. gingivalis LPS-upregulated
Expression of IL-6 and IL-8
HOKs were pre-treated with baicalin (0–80 mM) for 24 h, and
subsequently treated with fresh media containing P. gingivalis LPS
(10 mg/ml) with or without baicalin (0–80 mM) for 3 h. The
culture supernatants and total RNA were collected for ELISA and
real-time PCR analyses, respectively. We discovered that baicalin
at 40 mM and 80 mM significantly suppressed P. gingivalis LPS-
upregulated IL-6 mRNA expression (Fig. 1A); and baicalin at
10 mM, 20 mM, 40 mM and 80 mM significantly downregulated P.
gingivalis LPS-upregulated IL-6 protein expression (Fig. 1B).
Baicalin at 80 mM also significantly suppressed P. gingivalis LPS-
upregulated IL-8 mRNA and protein expression (Figs. 2A & 2B).
As baicalin at 80 mM contained 0.08% DMSO, the observed
downregulation could have been partially caused by DMSO. To
exclude this possibility, a vehicle control group was set up by
treating cells firstly with 0.08% DMSO for 24 h, and then with P.
gingivalis LPS (10 mg/ml) and 0.08% DMSO for 3 h. No DMSO-
mediated inhibition on IL-6 or IL-8 expression was found (Figs. 1
and 2).
Baicalin Displayed Inhibitory Effect on P. gingivalis LPS-
induced Activation of NF-kB, p38 MAPK and JNK
In resting cells, inactive NF-kB (p65/p50) is retained in the
cytoplasm by an inhibitory protein called IkBa [43]. Upon
stimulation, IkBa is ubiquitinated and degraded by 26 S
proteasome, resulting in the translocation of NF-kB to the nucleus
where it binds to the target genes and initiates gene transcription
[43]. As NF-kB plays a central role in P. gingivalis LPS-mediated
cell response and the expression of IL-6 and IL-8 is dependent on
NF-kB signaling [44], we were interested to exam whether
baicalin could have any inhibitory effects on P. gingivalis LPS-
Figure 3. Baicalin inhibits P. gingivalis LPS-induced activation of NF-kB, p38 MAPK and JNK. A. The representative western blot
experiment was performed by pooling cytoplasmic protein extracts equally from three independent experiments. 25 mg aliquots were loaded into
each lane. The membrane was firstly probed with the rabbit anti-phospho-IkBa mAbs (1:2000), and sequentially stripped and re-probed with rabbit
anti-phospho-p38 MAPK mAbs (1:2000), rabbit anti-phospho-JNK mAbs (1:2000), and rabbit anti-IkBa mAbs (1:2000). For loading control, the
membrane was probed with rabbit anti-a-tubulin mAbs (1:4000). B. The densitometry analysis of the signals. Cells treated with culture media alone
served as the blank control group, and those treated with P. gingivalis (P.g.) LPS (10 mg/ml) alone represented the positive control group. Cells treated
with P.g. LPS at 10 mg/ml and 0.08% DMSO served as the vehicle control group. Data of three independent experiments were depicted as relative fold
change as compared with the blank control group (set as 1). For the p-JNK protein, the positive control group (LPS) was set as 1 since the signals of
the blank control group at 15 min and 30 min were undetectable. *p,0.05 and **p,0.01 as compared with the respective positive control group
(LPS) at each time point. BI: baicain.
doi:10.1371/journal.pone.0051008.g003
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activated NF-kB. Cells were pre-treated with baicalin (80 mM) for
24 h, and thereafter treated with fresh media containing
P. gingivalis LPS (10 mg/ml) with or without baicalin (80 mM) for
15, 30, and 60 min. A vehicle control group was set up by treating
cells firstly with 0.08% DMSO for 24 h, and then with P. gingivalis
LPS (10 mg/ml) and 0.08% DMSO for 15, 30, and 60 min. As
shown in Fig. 3, baicalin significantly inhibited to different extents
P. gingivalis LPS-induced phosphorylation of IkBa, p38 MAPK
and JNK which act as the downstream of TLR2/4 signaling
pathways [45].
Baicalin Suppressed P. gingivalis LPS-induced Nuclear
Translocation of p65
The effect of baicalin on P. gingivalis LPS-induced nuclear
translocation of p65 was examined by using a p65 transcription
factor kit. Cells were pre-treated with baicalin (80 mM) for 24 h,
and then treated with fresh media containing P. gingivalis LPS
(10 mg/ml) with or without baicalin (80 mM) for 15, 30, and
60 min. Compared with P. gingivalis LPS-treated samples, baicalin
succeeded to suppress the amount of translocated p65 in the
nuclear protein extracts at 60 min (Fig. 4).
Baicalin Modulated P. gingivalis LPS-induced Expression
of Genes Associated with TLR Signaling
Lastly, a PCR array assay was undertaken to profile the
expression of genes associated with TLR signaling. Cells were pre-
treated with baicalin (80 mM) or culture media for 24 h, and then
treated with fresh media containing P. gingivalis LPS (10 mg/ml)
with or without baicalin (80 mM) for 3 h. The total RNA was
purified and reverse transcribed into cDNA templates. The
templates used in PCR array were pooled equally from three
independent experiments. Compared with the P. gingivalis LPS-
treated cells, the expression of CCL2, CSF2, CSF3, CXCL10, IL-
8, V-fos FBJ murine osteosarcoma viral oncogene homolog (FOS)
and interferon, beta 1, fibroblast (IFNB1) was significantly
downregulated over two folds in baicalin/P. gingivalis LPS treated
Figure 4. Baicalin suppresses P. gingivalis LPS-induced nuclear translocation of p65. A. The representative experiment was performed by
pooling nuclear protein extracts equally from three independent experiments. 2 mg aliquots were added to each well. The assay was carried out
according to the manufacturer’s instruction. B. The intensity analysis of the luminescent signals. Cells treated with culture media alone served as the
blank control group, and those treated with P. gingivalis (P.g.) LPS (10 mg/ml) alone represented the positive control group. Cells treated with P.g. LPS
at 10 mg/ml and 0.08% DMSO served as the vehicle control group. Data from three independent experiments were depicted as relative fold change as
compared with the blank control groups (set as 1). *p,0.05 and **p,0.01 as compared with the respective positive control group (LPS) at each time
point. BI: baicalin.
doi:10.1371/journal.pone.0051008.g004
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cells (Table 1). Notably, CCL2, CSF3 and CXCL10 were
markedly downregulated over four folds. On the other hand,
other genes including cluster of differentiation 80 (CD80),
interleukin-1 receptor-associated kinase 1 (IRAK1), jun proto-
oncogene (JUN), TLR6, Ubiquitin-conjugating enzyme E2 variant
1 (UBE2V1), sterile a and TIR motif–containing 1 (SARM1),
single Ig IL-1-related receptor (SIGIRR), TIR domain containing
adaptor protein (TIRAP) and TLR1 were significantly upregu-
lated over two folds in baicalin/LPS-treated cells (Table 1).
Discussion
Periodontal disease results essentially from the consequence of a
disrupted immuno-inflammatory homeostasis of bacteria-host
interactions [5]. In susceptible individuals, when host response
fails to limit and resolve early infection timely, cytokine expression
may become dysregulated and destructive to tissues [46,47]. As IL-
6 is a stimulator of bone resorption and IL-8 is a potent neutrophil
chemoattractant and activator [48,49], prolonged and excessive
production of these pro-inflammatory cytokines could contribute
to periodontal tissue damage. Our present study shows that
baicalin could significantly downregulate P. gingivalis LPS-upregu-
lated production of IL-6 and IL-8 in HOKs. This observation goes
in line with the concept of host modulatory therapy, suggesting
that baicalin could potentially be used for modulation of host
response in treatment of periodontal disease.
The present study also reveals that baicalin may inhibit
P. gingivalis LPS-induced activation of NF-kB, p38 MAPK and
JNK. Due to their involvements in a variety of human diseases,
NF-kB, p38 MAPK and JNK have become therapeutic targets
and several NF-kB inhibitors have been discovered, such as
sulindac [50], IKK inhibitor [51,52] and resveratrol [53]. It has
been shown that SD828, a p38 MAPK antagonist, could suppress
LPS-induced alveolar bone loss in periodontitis rats [54], and JNK
inhibitors like CEP-1347 and AS601245 exhibit protective effects
on neurons [55,56]. In the present study, the exact mechanism of
baicalin-induced inhibition of P. gingivalis LPS-upregulated expres-
sion of IL-6 and IL-8 in HOKs remains to be further elucidated.
While it could be speculated that the inhibition observed could
have been exerted directly on IKK, p38 MAPK and JNK; or on
the upstream kinases such as transforming-growth-factor-b-
activated kinase 1 (TAK1) (kinase of IKK and p38/JNK MAPK)
[57–59], interleukin-1 receptor-associated kinase 1 (IRAK1)
(kinase of TAK1), or IRAK4 (kinase of IRAK1) [60–62].
According to the PCR array results, CCL2 [63], CSF3 [64,65]
and CXCL10 [66] were greatly downregulated over four folds by
baicalin treatment. The transcription of CCL2 and CSF3 is
regulated by NF-kB [67,68]. In response to LPS, CXCL10 is
induced in a TLR4-mediated MyD88-independent pathway
[15,69,70]. The exact reasons that baicalin could downregulate
both LPS-induced MyD88-dependent and MyD88-independent
genes remain unclear. The possible mechanisms are as follows: i)
baicalin might enable to interfere with the binding of P. gingivalis
LPS to TLR4; ii) it could inhibit multiple downstream kinases of
TLR4 signaling, such as IKK, TAK1 and TANK-binding kinase 1
(TBK1) (kinase of IRF3) [71]; iii) as the optimal transcription of
CXCL10 requires a coordinated binding of activated IRF3 and
NF-kB to the promoter region [15,69], baicalin-mediated
inhibition of NF-kB could have interfered with the expression of
CXCL10. Further study is warranted to clarify these points.
Over the last three decades, the growing knowledge of
periodontal pathogenesis has appreciated the crucial role of host
response in the initiation and development of periodontal disease.
Recently, TLR signaling has become an attractive target of host
Table 1. The fold change in the expression of genes in
baicalin/P. gingivalis LPS-treated cells (test) with reference to
the P. gingivalis LPS-treated cells (control).
Wells Genes Fold Change Wells Genes Fold Change
A01 BTK 1.04 B01 ELK1 1.37
A02 CASP8 1.11 B02 FADD 1.86
A03 CCL2 0.13 B03 FOS 0.46
A04 CD14 0.67 B04 HMGB1 1.65
A05 CD80 2.30 B05 HRAS 1.22
A06 CD86 1.00 B06 HSPA1A 1.66
A07 CHUK 1.21 B07 HSPD1 1.52
A08 CLEC4E 0.80 B08 IFNA1 1.44
A09 CSF2 0.49 B09 IFNB1 0.41
A10 CSF3 0.21 B10 IFNG 1.04
A11 CXCL10 0.17 B11 IKBKB 1.08
A12 EIF2AK2 0.91 B12 IL10 1.04
C01 IL12A 0.96 D01 CD180 0.60
C02 IL1A 0.77 D02 LY86 1.04
C03 IL1B 0.72 D03 LY96 1.07
C04 IL2 1.04 D04 MAP2K3 1.13
C05 IL6 0.55 D05 MAP2K4 1.19
C06 IL8 0.34 D06 MAP3K1 1.42
C07 IRAK1 2.39 D07 MAP3K7 1.40
C08 IRAK2 0.64 D08 MAP3K7IP1 1.43
C09 IRF1 1.23 D09 MAP4K4 1.08
C10 IRF3 1.14 D10 MAPK8 1.16
C11 JUN 2.06 D11 MAPK8IP3 1.95
C12 LTA 1.21 D12 MYD88 1.26
E01 NFKB1 0.70 F01 RIPK2 1.28
E02 NFKB2 1.54 F02 SARM1 2.57
E03 NFKBIA 0.81 F03 SIGIRR 2.72
E04 NFKBIL1 1.35 F04 ECSIT 1.98
E05 NFRKB 1.84 F05 TBK1 1.07
E06 NR2C2 1.30 F06 TICAM2 1.58
E07 PELI1 1.27 F07 TIRAP 2.90
E08 PPARA 1.98 F08 TLR1 2.14
E09 PRKRA 1.28 F09 TLR10 1.20
E10 PTGS2 0.66 F10 TLR2 0.78
E11 REL 1.32 F11 TLR3 0.88
E12 RELA 1.54 F12 TLR4 1.04
G01 TLR5 0.72 H01 B2M 0.70
G02 TLR6 2.34 H02 HPRT1 0.96
G03 TLR7 1.04 H03 RPL13A 1.27
G04 TLR8 1.04 H04 GAPDH 0.97
G05 TLR9 0.73 H05 ACTB 1.21
G06 TNF 0.84
G07 TNFRSF1A 1.06
G08 TOLLIP 1.16
G09 TRAF6 1.35
G10 TICAM1 0.96
G11 UBE2N 1.20
The genes downregulated over four folds are highlighted in bold, and those up
or downregulated two to four folds are highlighted in italics.
doi:10.1371/journal.pone.0051008.t001
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modulation therapy due to its central role in activating immuno-
imflammatory response in the development of periodontitis [72].
To date, a number of negative regulatory strategies for over-
activated TLR signaling have been proposed, such as natural/
synthetic antagonists [73,74], BB-loop peptides [75], miRNA [76]
and kinase inhibitors [77]. Here, we report for the first time that
baicalin can significantly downregulate P. gingivalis LPS-upregu-
lated IL-6 and IL-8 expression in HOKs, through negative
regulation of TLR signaling. Based on these findings, baicalin may
potentially serve as a host response modulator in the control of
periodontal disease by negative regulation of TLR signaling.
Further clinical study is warranted to investigate the effectiveness
of baicalin as a potential adjunct in treatment of patients with
inflammatory diseases like periodontal disease.
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